Roche Media 2026-01-29 Roche GLP-1 produces “robust” weight loss in late-stage obesity trial - European Pharmaceutical Review
Roche Media 2026-01-29 Roche drops $100M Kiniksa fibrosis drug from phase 2 pipeline as part of quarterly clearout - Fierce Biotech
Roche Media 2026-01-27 Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec - Pharmaceutical Executive
Roche Media 2026-01-27 How Roche is Scaling Production After Obesity Breakthrough - Manufacturing Digital Magazine
Roche Media 2026-01-27 Roche sees GLP1/GIP drug from Carmot produce 22.5% weight loss, readies phase 3 trial - Fierce Biotech
Roche Media 2026-01-27 Roche announces positive phase II results for experimental obesity drug - wkzo.com
Roche Media 2026-01-26 Roche's Gazyva gets Health Canada approval for lupus nephritis - marketscreener.com
Roche Media 2026-01-09 Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com
Roche Media 2026-01-09 Roche returns to Chinese biotech MediLink for another ADC pact - Endpoints News
Roche Media 2026-01-09 Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech
Roche Media 2026-01-06 In Structure licensing deal, Roche commits $100M to shore up GLP-1 position - Fierce Biotech
Roche Media 2026-01-06 Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement - BioSpace
Roche Media 2026-01-01 AI-based Digital Pathology Market Intelligence Report, 2025-2035, Featuring Aiforia Technologies, Ibex Medical Analytics, Indica Labs, PathAI, Roche, Visiopharm and Many Other Key Players - ResearchAndMarkets.com - The AI Journal
Roche Media 2025-12-26 Emerson and Roche Collaborate on Digital Modality Library for Pharmaceutical Development - Automation World
Roche Media 2025-12-22 Roche Lunsumio VELO bags USFDA approval for subcutaneous use in follicular lymphoma - Medical Dialogues